239 related articles for article (PubMed ID: 31136005)
1. KMT2A (MLL) fusions in aggressive sarcomas in young adults.
Yoshida A; Arai Y; Tanzawa Y; Wakai S; Hama N; Kawai A; Shibata T
Histopathology; 2019 Oct; 75(4):508-516. PubMed ID: 31136005
[TBL] [Abstract][Full Text] [Related]
2. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
[TBL] [Abstract][Full Text] [Related]
3. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
5. KMT2A-rearranged sarcoma with unusual fusion gene CBX6::KMT2A::PYGO1.
Nakamura H; Kukita Y; Wakamatsu T; Takenaka S; Yoshida K; Yagi T
Virchows Arch; 2023 Dec; 483(6):891-897. PubMed ID: 37713130
[TBL] [Abstract][Full Text] [Related]
6. Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.
Kao YC; Sung YS; Zhang L; Huang SC; Argani P; Chung CT; Graf NS; Wright DC; Kellie SJ; Agaram NP; Ludwig K; Zin A; Alaggio R; Antonescu CR
Am J Surg Pathol; 2016 Aug; 40(8):1009-20. PubMed ID: 26945340
[TBL] [Abstract][Full Text] [Related]
7. VIM::KMT2A-rearranged sarcomas: A report of two new cases confirming an entity with distinct histologic features.
Almohsen SS; Griffin AM; Dickson BC; Demicco EG
Genes Chromosomes Cancer; 2023 Jul; 62(7):405-411. PubMed ID: 36959690
[TBL] [Abstract][Full Text] [Related]
8. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
9. First case of B ALL with KMT2A-MAML2 rearrangement: a case report.
Menu E; Beaufils N; Usseglio F; Balducci E; Lafage Pochitaloff M; Costello R; Gabert J
BMC Cancer; 2017 May; 17(1):363. PubMed ID: 28535805
[TBL] [Abstract][Full Text] [Related]
10. Insertion of the CXXC domain of KMT2A into YAP1: An unusual mechanism behind the formation of a chimeric oncogenic protein.
Teku G; Nilsson J; Magnusson L; Sydow S; Flucke U; Puls F; Mitra S; Mertens F
Genes Chromosomes Cancer; 2023 Nov; 62(11):633-640. PubMed ID: 37246732
[TBL] [Abstract][Full Text] [Related]
11. Novel NTRK3 Fusions in Fibrosarcomas of Adults.
Yamazaki F; Nakatani F; Asano N; Wakai S; Sekimizu M; Mitani S; Kubo T; Kawai A; Ichikawa H; Yoshida A
Am J Surg Pathol; 2019 Apr; 43(4):523-530. PubMed ID: 30520818
[TBL] [Abstract][Full Text] [Related]
12. New fusion sarcomas: histopathology and clinical significance of selected entities.
Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J
Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925
[TBL] [Abstract][Full Text] [Related]
13. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
14. The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.
Ragusa D; Makarov EM; Britten O; Moralli D; Green CM; Tosi S
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1207. PubMed ID: 32721124
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
[TBL] [Abstract][Full Text] [Related]
17. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.
Peters TL; Kumar V; Polikepahad S; Lin FY; Sarabia SF; Liang Y; Wang WL; Lazar AJ; Doddapaneni H; Chao H; Muzny DM; Wheeler DA; Okcu MF; Plon SE; Hicks MJ; López-Terrada D; Parsons DW; Roy A
Mod Pathol; 2015 Apr; 28(4):575-86. PubMed ID: 25360585
[TBL] [Abstract][Full Text] [Related]
18. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
[TBL] [Abstract][Full Text] [Related]
19. Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults.
Yoshida A; Arai Y; Hama N; Chikuta H; Bando Y; Nakano S; Kobayashi E; Shibahara J; Fukuhara H; Komiyama M; Watanabe SI; Tamura K; Kawai A; Shibata T
Histopathology; 2020 Mar; 76(4):509-520. PubMed ID: 31647130
[TBL] [Abstract][Full Text] [Related]
20. Sarcomas with sclerotic epithelioid phenotype harboring novel EWSR1-SSX1 fusions.
Antonescu CR; Rosenberg AE; Xie Z; Zhang L; Perell KA; Loya AC
Genes Chromosomes Cancer; 2021 Sep; 60(9):616-622. PubMed ID: 33987888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]